www.CINGT.info - Cochlear Implant Neurotrophin Gene Therapy Clinical Trial
A phase I/II non-randomized, controlled trial, evaluating the safety and efficacty of neurotrophin gene therapy delivered during cochlear implant surgery ANZCTR reg. no.ACTRN12618001556235 |
Background | Personnel & support | Publications & CoIs | About Cochlear Implants | Contacts |
Contacts |
What should I do if I have further questions about my involvement in the study? The person you need to contact will depend on the nature of your query. If you require further information regarding this study, or if you have any problems which may be related to your involvement in the study, you can contact the following member/s of the research team: Patient Primary Contact Information
Clinical Trial Co-ordinators These people are your primary contact and will accompany you during your visits to NextSense and the Macquarie University Hearing Hub. They are able talk to you about the practical aspects of this clinical trial, including support for the in-home hearing testing parts of the study |
Dr Fadwa Al Nafjan |
|
Position |
Audiologist and Macquarie University CINGT Clinical Trial Manager, Macquarie University's Australian Hearing Hub |
Telephone |
(02) 9385 3134 |
Dr Wai Kong Lai
|
|
Position |
NextSense Clinical Trial Manager, NextSense Patient support for CINGT clinical trial, information and visits, and medical liaison |
|
|
Ms Rachelle Hassarati
|
|
Position |
NextSense Clinical Trial Operations,NextSense Patient support for CINGT clinical trial, information and visits, and medical liaison |
|
|